VitaminD supplementation for the prevention and treatment of COVID-19: a position statement from the Spanish Society of Geriatrics and Gerontology |
| |
Authors: | Francisco J Tarazona-Santabalbina Leonor Cuadra José Manuel Cancio Ferran Roca Carbonell Juan Manuel Pérez-Castejón Garrote Álvaro Casas-Herrero Nicolás Martínez-Velilla José Antonio Serra-Rexach Francesc Formiga |
| |
Institution: | 1. Geriatric Service, Hospital Universitario de la Ribera, Alzira, Valencia, Spain. CIBERFES, Centro de Investigación Biomédica en Red Fragilidad y Envejecimiento Saludable, Madrid, Spain;2. Departament of Geriatric Medicine and Palliative Care, Badalona Serveis Assistencials, Barcelona, Spain. Catalonia Geriatrics and Gerontology Society, Barcelona, Spain;3. Centro Sociosanitario El Carme, Servicio de Geriatría y Cuidados Paliativos de BSA (Badalona Servicios Asistenciales), Badalona, Spain;4. Badalona Welfare Services: Badalona Serveis Assistencials SA, Badalona, Spain;5. Servicio de Geriatría Hospital Universitari de la Santa Creu, Vic, Spain;6. Hospital Universitari de Vic: Hospital General de Vic, Spain;7. Doctor en Medicina por la UB Especialista en Geriatria, Jefe del Servicio de Geriatria y Cuidados Paliativos de Badalona Serveis Assistencials BSA, CSS El Carme Badalona, Spain;8. Navarrabiomed, Complejo Hospitalario de Navarra (CHN), (UPNA), IdiSNA, Pamplona, Spain;9. CIBER of Frailty and Healthy Aging (CIBERFES), Instituto de Salud Carlos III, Madrid, Spain;10. Hospital de Navarra: Complejo Hospitalario de Navarra, Spain;11. Jefe del Servicio de Geriatría Hospital General Universitario Gregorio Marañón Profesor Titular de Medicina, Departarmento de Medicina, Facultad de Medicina Universidad Complutense CIBER-Fragilidad y Envejecimiento Saludable Madrid, Spain;12. Hospital General Universitario Gregorio Marañón: Hospital General Universitario Gregorio Maranon, Spain;13. Programa de Geriatría, Servicio medicina Interna, Hospital de Bellvitge, L’Hospitalet de Llobregat, Barcelona, Spain;14. Systemic Diseases and Ageing Group, Cardiovascular, Respiratory and Systemic Diseases and Cellular Ageing Program, Translational Medicine Area, Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet de Llobregat, Spain |
| |
Abstract: | The coronavirus disease 2019 (COVID-19) produces severe respiratory symptoms such as bilateral pneumonia associated to a high morbidity and mortality, especially in patients of advanced age. Vitamin D deficiency has been reported in several chronic conditions associated with increased inflammation and dysregulation of the immune system. Vitamin D in modulates immune function too. Vitamin D receptor (VDR) is expressed by most immune cells, including B and T lymphocytes, monocytes, macrophages, and dendritic cells and the signalling of vitamin D and VDR together has an anti-inflammatory effect. Some studies have reported that vitamin D treatment could be useful for the prevention and treatment of COVID-19 because vitamin D plays an important role as a modulator of immunocompetence. Over the last few months, some studies have hypothesized the possible beneficial effect of vitamin D supplementation in patients with COVID-19 in order to improve the immune balance and prevent the hyperinflammatory cytokine storm. Some preliminary studies have already shown promising results with vitamin D supplementation in hospitalized COVID-19 patients. Vitamin D should be administered daily until adequate levels are achieved due to vitamin D behaves as a negative acute phase reactant (APR). Despite the lack of evidence on specific doses of vitamin D to treat COVID-19 in older adults, authors consider it is necessary to standardize the use in clinical practice. These recommendations advice supplement vitamin D in a protocoled fashion based on expert opinions, level of evidence 5. |
| |
Keywords: | COVID-19 Vitamin D Frailty SARS-CoV-2 Older adults COVID-19 Vitamina D Fragilidad SARS-CoV-2 Adultos mayores |
本文献已被 ScienceDirect 等数据库收录! |
|